INVO Fertility, Inc. Files 8-K for Material Agreement
Ticker: IVF · Form: 8-K · Filed: Sep 26, 2025 · CIK: 1417926
Sentiment: neutral
Topics: material-agreement, filing-update
TL;DR
INVO Fertility just signed a big deal, filing an 8-K with new agreements and financials.
AI Summary
On September 22, 2025, INVO Fertility, Inc. entered into a Material Definitive Agreement. The filing also includes financial statements and exhibits related to this agreement. The company was formerly known as NAYA Biosciences, Inc. until October 22, 2024.
Why It Matters
This 8-K filing indicates a significant new agreement for INVO Fertility, Inc., which could impact its business operations and financial performance.
Risk Assessment
Risk Level: medium — Material Definitive Agreements can introduce new risks or opportunities, and the details within the filing are crucial for assessing the impact.
Key Players & Entities
- INVO Fertility, Inc. (company) — Registrant
- NAYA Biosciences, Inc. (company) — Former company name
- September 22, 2025 (date) — Date of earliest event reported
- October 22, 2024 (date) — Date of name change from NAYA Biosciences, Inc.
FAQ
What is the nature of the Material Definitive Agreement entered into by INVO Fertility, Inc. on September 22, 2025?
The filing indicates the entry into a Material Definitive Agreement, but the specific details of the agreement are not provided in the provided text.
What are the key financial statements and exhibits included with this 8-K filing?
The filing states that financial statements and exhibits are included, but their specific content is not detailed in the provided text.
When did INVO Fertility, Inc. change its name from NAYA Biosciences, Inc.?
INVO Fertility, Inc. changed its name from NAYA Biosciences, Inc. on October 22, 2024.
What is the state of incorporation for INVO Fertility, Inc.?
INVO Fertility, Inc. is incorporated in Nevada.
What is the business address of INVO Fertility, Inc.?
The business address of INVO Fertility, Inc. is 5582 Broadcast Court, Sarasota, FL 34240.
Filing Stats: 1,073 words · 4 min read · ~4 pages · Grade level 13 · Accepted 2025-09-26 17:30:01
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value IVF The Nasdaq Stock Mark
- $1,500,000 — h the Lender advanced a gross amount of $1,500,000 to the Company. The foregoing summary
- $1,000,000 b — t receive equity investment of at least $1,000,000 by November 30, 2024. The foregoing sum
- $500,000 — hings, to pay down its loan by at least $500,000 and increase its monthly payments by up
- $30,000 — increase its monthly payments by up to $30,000 if the Company closes a private offerin
- $20,000 — t under the Loan Agreement increased by $20,000, and (d) the Company agreed to reimburs
- $17,500 — reimburse the Lender for approximately $17,500 in fees and expenses incurred in connec
- $1 million — Company did not raise the above stated $1 million by November 30, 2024 as required under
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex10-1.htm (EX-10.1) — 31KB
- ex10-1_001.jpg (GRAPHIC) — 322KB
- 0001493152-25-015821.txt ( ) — 683KB
- ivf-20250922.xsd (EX-101.SCH) — 3KB
- ivf-20250922_lab.xml (EX-101.LAB) — 33KB
- ivf-20250922_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 26, 2025 INVO FERTILITY, INC. /s/ Steven Shum Steven Shum Chief Executive Officer